Russell Investments Group’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
72,222
+31,979
+79% +$344K ﹤0.01% 2430
2026
Q1
$340K Buy
40,243
+14,417
+56% +$158K ﹤0.01% 2657
2025
Q4
$292K Buy
25,826
+5,201
+25% +$64.4K ﹤0.01% 2697
2025
Q3
$310K Sell
20,625
-879
-4% -$12.8K ﹤0.01% 2652
2025
Q2
$303K Sell
21,504
-37,564
-64% -$669K ﹤0.01% 2519
2025
Q1
$1.42M Sell
59,068
-87,057
-60% -$3.07M ﹤0.01% 1878
2024
Q4
$5.46M Sell
146,125
-16,752
-10% -$782K 0.01% 1119
2024
Q3
$8.14M Buy
162,877
+80,558
+98% +$3.13M 0.01% 926
2024
Q2
$2.86M Buy
82,319
+74,890
+1,008% +$2.96M ﹤0.01% 1453
2024
Q1
$406K Buy
7,429
+3
+0% +$149 ﹤0.01% 2266
2023
Q4
$318K Hold
7,426
– – ﹤0.01% 2333
2023
Q3
$193K Sell
7,426
-20,260
-73% -$421K ﹤0.01% 2500
2023
Q2
$662K Hold
27,686
– – ﹤0.01% 2122
2023
Q1
$378K Sell
27,686
-1,382
-5% -$22K ﹤0.01% 2343
2022
Q4
$403K Buy
+29,068
New +$410K ﹤0.01% 2350

Other funds holding BHVN

Russell Investments Group's BHVN Position: Q2 2026 in Review

Russell Investments Group increased its Biohaven (BHVN) stake by 79% in Q2 2026, buying an estimated $344K and bringing the position to 72,222 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

Russell Investments Group first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.14M in Q3 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Russell Investments Group held 72,222 shares of Biohaven worth $1.07M as of Q2 2026.
  • Russell Investments Group bought 31,979 Biohaven shares in Q2 2026, an estimated $344K.
  • Biohaven made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2430 holding.
  • Russell Investments Group first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Russell Investments Group's Biohaven position peaked at $8.14M in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.